Antiphospholipid Syndrome.

The article offers information on a study which examined whether patients with antiphospholipid antibodies (aPL) and thrombocytopenia and/or autoimmune hemolytic anemia (AIHA) presented with clinical criteria of antiphopholipid syndrome (APS) during follow-up. In view of the presence of lupus anticoagulant (LAC) in patients with thrombocytopenia, a subset of patients with high risk for developing thrombosis during follow-up was identified. The results provided a rationale for studies to evaluate the need for anticoagulant in these patients.